4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-21-015838
Options or other derivatives
- Chief Development Officer acquired 116,201 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Machatha Stephen Chief Development Officer | 2021-04-12 | Grant or award · Employee Stock Option (Right to Buy) | +116,201 | 116,201 | D | ||
Loading xslF345X03/doc4.xml…